Skip to main content

Table 1 Demographic details of Aortic Stenosis and haemodialysis patients

From: Defining myocardial fibrosis in haemodialysis patients with non-contrast cardiac magnetic resonance

Variable Aortic Stenosis patients (areas of discrete signal increase on native T1)
(n = 25)
Haemodialysis patients areas of discrete signal increase on native T1)
(n = 25)
Haemodialysis patients (no areas of discrete signal increase on native T1)
(n = 19)
Age (years) 66.9 ± 13.7 58.1 ± 16.5 49.9 ± 16.9
Male (n, %) 18 (72) 18 (72) 16 (84)
BMI (kg/m2) 29.4 ± 4.4 27.8 ± 6.8 27.9 ± 6.4
Dialysis Vintage (months) 35.4 ± 25.8 26.9 ± 21.6
Haemoglobin (g/L) 14.5 ± 1.2 11.4 ± 1.6 10.4 ± 1.6
HbA1c (%) 5.9 ± 0.9 5.4 ± 1.8 5.4 ± 0.6
SBP (mmHg) 158.8 ± 21.4 152.6 ± 22.5 127.6 ± 25.8
DBP (mmHg) 78.3 ± 9.6 79.5 ± 10.5 72.5 ± 19.1
HR (bpm) 70.1 ± 10 72.8 ± 12.5 78.1 ± 11.1
Past medical and drug history
 Hypertension (n, %) 18 (72) 21 (84) 11 (58)
 Diabetes (n, %) 4 (16) 7 (28) 4 (21)
 CAD (n, %) 11 (44) 9 (36) 4 (21)
 Prev MI (n, %) 3 (12) 5 (20) 1 (5)
 ACEi (n, %) 7 (28) 2 (8) 1 (5)
 ARB (n, %) 4 (16) 3 (12) 1 (5)
 Diuretic (n, %) 7 (28) 3 (12) 4 (21)
 Beta Blocker (n, %) 10 (40) 12 (48) 6 (32)
 Statin (n, %) 17 (68) 14 (56) 5 (26)
 Calcium Channel Blocker (n, %) 11 (44) 11 (44) 5 (26)
 Number of antihypertensives 1.6 ± 1.2 1.4 ± 0.9 1.3 ± 1.1
Left Ventricular mass and volumes (CMR)
 LVEDV (ml) 190.3 ± 43.4 198.8 ± 54.3 160.1 ± 48
 LVEF (%) 56.5 ± 6.5 52.2 ± 6.4 50.5 ± 6.2
 LVM (g) 135.4 ± 42.4 116.1 ± 29.4 104.1 ± 45.3
 LVM/LVEDV (g/ml) 0.71 ± 0.1 0.59 ± 0.1 0.62 ± 0.1
  1. Mean values with standard deviation expressed as n ± SD. N, % = Chi-squared. bpm, beats per minute; ACEi angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, CAD coronary artery disease, CMR cardiac MRI, DBP diastolic blood pressure, HR heart rate, HTN hypertension, LVEDV left ventricular end-diastolic volume, LVEF left ventricular ejection fraction, LVMi left ventricular mass index, MI myocardial infarction, SBP systolic blood pressure